Cardiac troponins and their current clinical application;Utilidad clínica de las troponinas cardíacas

Medicina Clinica

Volumn 120, Issue 10, 2003, Pages 389-394

  Lafuente Gormaz, Carlos ^a   Terrancle de Juan, Ignacio ^a   Broseta Viana, Luis ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTIINFECTIVE AGENT; BIOCHEMICAL MARKER; CREATINE KINASE MB; DALTEPARIN; ENOXAPARIN; HEPARIN DERIVATIVE; TIROFIBAN; TROPONIN; TROPONIN C; TROPONIN I; TROPONIN T;

CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVERSION; CHEMOTHERAPY; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DILATATION; DIAGNOSTIC TEST; DISEASE MARKER; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HUMAN; LUNG EMBOLISM; PREDICTION; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

EID: 0038746926     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13044726     Document Type: Review

References (88)

1. Tobacman LS. Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol 1996;58:447-81.
2. Bucher EA, Maisonpierre PC, Konieczny SF, Emerson CP. Expression of the troponin complex genes: transcriptional coactivation during myoblast differentiation and independent control in heart and skeletal muscles. Mol Cell Biol 1988;8:4134-42.
3. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991;67:1360-7.
4. Voss EM, Sharkey SW, Gernert AE, Murakami MM, Johnston RB, Hsieh CC, et al. Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and disease myocardium. Infarct sizing using serum profiles. Arch Pathol Lab Med 1995;119:799-806.
5. Adams JE, Schechtman KB, Landt Y, Ladenson JH, Jaffe AS. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994;40 (7 Pt 1):1291-5.
6. Mair J, Morandell D, Genser N, Lechleitner P, Dientl F, Puschendorf B. Equivalent early sensitivities of myoglobin, cretine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. Clin Chem 1995;41:1266-72.
7. Adams J, Abendschein D, Jaffe A. Biochemical markers of myocardial injury; is MB creatine kinase the choice for the 1990? Circulation 1993;88:750-63.
8. Galán A. Diagnóstico bioquímico de la isquemia coronaria aguda. Med Clin (Barc) 2000;115:671-6.
9. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined. A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13.
10. Panteghini M. Acute coronary syndrome. Biochemical strategies in the troponin era. Chest 2002;122:1428-35.
11. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients whith unstable angina and non-ST elevation myocardial infarction. JAMA 2001;286:2405-12.
12. Dasgupta A, Wells A, Biddle DA. Negative interference of bilirrubin and hemoglobin in the MEIA troponin I assay but not in the MEIA CK-MB assay. J Clin Lab Anal 2001;15:76-80.
13. Stiegler H, Fischer Y, Vázquez-Jiménez JF, Graft J, Filzmaier K, Fausten B, et al. Lower cardiac troponin T and I results in heparin-plasma than in serum. Clin Chem 2000;46:1338-44.
14. Siegel AJ, Sholar M, Yang J, Dhanak E, Lewandrowski KB. Elevated cardiac markers in asyntomatic marathonmen. Stuning myocardium? Cardiology 1997;88:487-91.
15. Bodor GS, Survant L, Voss EM, Smith S, Porterfield D, Apple FS. Cardiac troponin T composition in normal and regenerating human skeletal muscle. Clin Chem 1997;43:476-84.
16. García de la Villa B, Díaz-Buschmann I, Jurado A García R, Parra FJ, Medina J, et al. Valor de la troponina I cardíaca como prueba diagnóstica en el estudio del dolor torácico. Rev Esp Cardiol 1998;51:122-8.
17. Greenson N, Macoviak J, Krishnaswamy P, Morrisey R, James C, Clopton P, et al. Usefulness of cardiac troponin I in patients undergoing open heart surgery. Am Heart J 2001;141:447-55.
18. Bonnefoy E, Godon P, Kirkorian G, Fatemi M, Chevalier P, Touboul P. Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. Eur Heart J 2000;21:832-6.
19. McCaig LF. National Hospital ambulatory medical care survey: 1992 emergency department summary. Advance Data No. 245, 1994.
20. Graff LG, Dallara J, Ross MA, Joseph AJ, Itzcovitz J, Andelman RP, et al. Impact on the care of the emergency department chest pain patient from the chest pain evaluation registry (CHEPER) study. Am J Cardiol 1997;80:563-8.
21. Lee TH, Cook EF, Weisberg M, Sargent RK, Wilson C, Goldman L. Acute chest pain in the emergency room. Identification and examination of low-risk patients. Arch Intern Med 1985;145:65-9.
22. Lee TH, Rouan GW, Weisberg MC, Brand DA, Acampora D, Stasiulewicz C, et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol 1987;60:219-24.
23. Antman EM, Grudzien C, Mitchell RN, Sacks DB. Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T. Am Heart J 1997;133:596-8.
24. Muñoz R, García Robles JA, González E, Jiménez FJ. Angina inestable. En: Delcán JL, editor. Cardiopatía Isquémica. Madrid: ENE Ediciones, 1999; p. 422-6.
25. Hutter AM, Amsterdam EA, Jaffe AS for Task Force 2B. Chest discomfort evaluation in the hospital. 31st Bethesda Conference: emergency cardiac care (1999). J Am Coll Cardiol 2000;35:826-80.
26. Newby LK, Kaplan AL, Granger BB, Sedorf F, Califf RM, Ohman EM. Comparison of cardiac troponin T versus CK-MB for risk stratification in a Chest Pain Evaluation Unit. Am J Cardiol 2000;85:801-5.
27. DeFilippi CR, Parmar RJ, Potter MA, Tocchi M. Diagnostic accuracy, angiographic correlates and long term risk stratification with troponin T ultra sensitive rapid assay in chest pain patients at low risk for acute myocardial infarction. Eur Heart J 1998;19 (Supl N): N42-N47.
28. Capdevila C, Portolés M, Hernándiz A, Pallarés V, Cosín J. La troponina T como posible marcador del daño miocárdico menor. La aplicación en el miocardio aturdido y en la isquemia silente. Rev Esp Cardiol 2001; 54:580-91.
29. Villanueva FS, Sabia PJ, Afrookteh A, Pollock SG, Hwang LJ, Kaul S. Value and limitations of current methods of evaluating patients presenting to the emergency room with cardiac-related symptoms for determining long-term prognosis. Am J Cardiol 1992;69:746-50.
30. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-53.
31. Almeda FQ, Calvin JE, Parrillo JE, Sun FG, Barron JT. Prevalence of angiographically significant stenosis in patients with chest pain and elevated troponin I level and normal CK and CK-MB levels. Am J Cardiol 2001;87:1286-9.
32. Kontos MC, Anderson FP, Alimard R, Ornato JP, Tatum JL, Jesse RL. Ability of troponin I to predict cardiac events in patients admitted from the emergency department. J Am Coll Cardiol 2000;36:1818-23.
33. Hamm CW. Progress in the diagnosis of unstable angina and perspectives for treatment. Eur Heart J 1998; 19 (Supl N):N48-N50.
34. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS et al. ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Forrce on practice Guidelines (Committee on management of patients with unstable angina). Circulation 2000;102:1193-209.
35. Lindahl B, Venge P, Wallentin L (BIOMACS Study Group). Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. Coron Artery Dis 1995;6:321-8.
36. Fleming SM, Daly KM. Cardiac troponins in suspected acute coronary syndrome. A meta-analysis of published trials. Cardiology 2001;95: 66-73.
37. Lüscher MS, Thygesen K, Ravkilde J, Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM study group. Thrombin inhibition in myocardial ischemia. Circulation 1997;96:2578-85.
38. Christenson RH, Duh SH, Newby LK, Ohman EM, Califf RM, Granger CB, et al. Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa investigators. Clin Chem 1998;44:494-501.
39. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-53.
40. Wu AH, Abbas S, Green S, Pearsall L, Dhakam S, Azar R, et al. Prognostic value of cardiac troponin T in unstable angina pectoris. Am J Cardiol 1995;76:970-2.
41. Galvani M, Ottani F, Ferrini D, Ladenson JH, Destro A, Baccos D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997;95:2053-9.
42. Polanczyk CA, Lee TH, Cook EF, Walls R, Wybenga D, Printy-Klein G, et al. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J Am Coll Cardiol 1998;32:8-14.
43. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation 1996;93:1651-7.
44. Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljungdahl L, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146-50.
45. Olatidoye AG, Wu AH, Feng YJ, Waters D. Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies. Am J Cardiol 1998;81:1405-10.
46. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, et al. Cardiac troponin T levels for risk stratification in acute myocardial infarction. The GUSTO-IIa investigators. N Engl J Med 1996;335:1333-41.
47. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Pratice Guidelines (Committee on the Management of Patients With Unstable Angina). 2002. Disponible en: http://www.acc.org/clinical/guidelines/unstable/unstable.pdf.
48. Collinson PO. Troponin T or troponin I or CK-MB (or none?). Eur Heart J 1998;19 (Supl N):N16-N24.
49. Ottani F, Galvani M, Ferrini D, Ladenson JH, Puggioni R, Destro A, et al. Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina. Am Heart J 1999;137:190-2.
50. Antman EM, Tranasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndroms. N Engl J Med 1996;335:1342-9.
51. Newby LK, Christenson RH, Ohman EM, Armstrong PW, Thompson TD, Lee KL, et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa investigators. Circulation 1998;98:1853-9.
52. Pettijohn TL, Doyle T, Spiekerman AM, Watson LE, Riggs MW, Lawrence ME. Usefulness of positive troponin T and negative creatine kinase levels in identifying high-risk patients with unstable angina pectoris. Am J Cardiol 1997;80:510-1.
53. Lindahl B, Venge P, Wallentin L for the FRISC Study Group. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol 1997;29:43-8.
54. Morrow DA, Antman EM, Tanasijevic M, Rifai N, de Lemos JA, McCabe CH, et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI 11B substudy. J Am Coll Cardiol 2000;36:1812-7.
55. Hamm CW, Heeschen C, Goldmann BU, Vahanian A, Adgey J, Miguel CM, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. C7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 1999;340:1623-9.
56. Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of trofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet 1999;354:1757-62.
57. Nageh T, Sherwood RA, Harris BM, Thomas MR. Cardiac troponin I for risk stratification following percutaneous coronary artery intervention in acute coronary syndromes. Catheter Cardiovasc Interv 2002;55:37-42.
58. Zimmerman J, Fromm R, Meyer D, Boudreaux A, Wun CH, Smalling R, et al. Diagnostic Marker Cooperative Study for the Diagnosis of Myocardial Infarction. Circulation 1999;99:1671-7.
59. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on standarization of clinical nomenclature. Circulation 1979;59:607-9.
60. Panteghini M. Biochemical markers of cardiac damage: what is current, what is redundant? Bochim Clin 2000;24:431-8.
61. Mair J, Wagner I, Morass B, Fridrich L, Lechleitner P, Dienstl F, et al. Cardiac troponin I release correlates with myocardial infarction size. Eur J Clin Chem Clin Biochem 1995;33:869-72.
62. Remppis A, Ehlermann P, Giannitsis E, Greten T, Most P, Muller-Bardorff M, et al. Cardiac troponin T levels at 96 hours reflect myocardial infarct size: a Pathoanatomical study. Cardiology 2000;93:249-53.
63. Rao AC, Collinson PO, Canepa-Anson R, Joseph SP. Troponin T measurement after myocardial infarction can identify left ventricular ejection of less than 40%. Heart 1998;80:223-5.
64. Ohman EM, Armstrong PW, White HD, Granger CB, Wilcox RG, Weaver WD, et al. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTO III investigators. Am J Cardiol 1999;84:1281-6.
65. Tanasijevic MJ, Cannon CP, Antman EM, Wybenga DR, Fischer GA, Grudzien C, et al. Myoglobin, creatine-kinase-MB and cardiac troponin I 60 minute ratios predict infarct related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B. J Am Coll Cardiol 1999;34: 739-47.
66. Saadeddin SM, Habbab MA, Sobki SH, Ferns GA. Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: clinical outcome. Ann Clin Biochem 2002 Jul;39 (Pt 4):392-7.
67. Garbarz E, Iung B, Lefevre G, Makita Y, Farah P, Michaud P, et al. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol 1999;84:515-8.
68. Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997;96:2953-8.
69. Del CC, O'Connor. Cardiac troponins in the congestive heart failure. Am Heart J 1999;138:653.
70. Missov E, Mair J. A novel biochemical approach to congestive heart failure: cardiac troponin T. Am Heart J 1999;138 (1 Pt 1):95-9.
71. Sato Y, Yamada T, Taniguchi R, Nagai K, Makiyama T, Okada H, et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001;103:369-74.
72. Setsuta K, Seino Y, Takahashi N, Ogawa T, Sasaki K, Harada A, et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 1999;84:608-11, A9.
73. Dengler TJ, Zimmermman R, Braum K, Mullerbardorff M, Zehelein J, Sack FU, et al. Elevated serum concentrations of cardiac troponin T in acute allograft rejection after human heart transplantation. J Am Coll Cardiol 1998;32:405-12.
74. Walpoth BH, Celik B, Printzen G, Peheim E, Colombo JP, Schaffner T, et al. Assessment of troponin T for detection of clinical cardiac rejection. Transpl Int 1998;11(Supl 1):S502-7.
75. Potapov EV, Ivanitskaia EA, Loebe M, Muckel M, Muller C, Sodian R, et al. Value of cardiac troponin I and T for selection of heart donors and as predictors of early graft failure. Transplantation 2001;71:1394-400.
76. Lund M, French JK, Johnson RN, Williams BF, White HD. Serum troponin T and I after elective cardioversion. Eur Heart J 2000;21:245-53.
77. Del Rey Sánchez JM, Hernández Madrid A, González Rebollo JM, Pena Pérez G, Rodríguez A, Savova D, et al. Cardioversión eléctrica externa y sistema de cardioversión interna: Evaluación prospectiva y comparativa del daño celular con troponina I. Rev Esp Cardiol 2002; 55:227-34.
78. Schluter T, Baum H, Plewan A, Neumeier D. Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage. Clin Chem 2001 Mar;47:459-63.
79. Andrews N, Jenkins J, Andrews G, Walker P. Using postoperative cardiac troponin I levels to detect myocardial ischaemia in patients undergoing vascular surgery. Cardiovasc Surg 2001;9:254-65.
80. Castro J, Vázquez S, Velayos C, Herranz J, Almería C, Illoro M. Troponina I cardíaca en el infarto de miocardio perioperatorio tras cirugía de revascularización coronaria. Rev Esp Cardiol 2002;55:245-50.
81. Ponce G, Romero JL, Hernández G, Padrón A, Cabrera E, Abad C. El infarto no Q en cirugía cardíaca valvular. Diagnóstico mediante troponina I. Rev Esp Cardiol 2001;54:1175-82.
82. Benoit MO, Paris M, Silleram J, Fiemeyer A, Moatti N. Cardiac troponin I: Its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery. Crit Care Med 2001;29:2023-4.
83. Januzzi JL, Lewandrowski K, MacGillivray TE, Newell JB, Kathiresan S, Servoss SJ, et al. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol 2002 May 1;39:1518-23.
84. Chapelle JP, Dubois B, Bovy C, Aldenhoff MC, Gielen J, Rorive G. Comparison of plasma cardiac troponins T and I in chronically hemodialyzed patients in relation to cardiac status and age. Clin Chem Lab Med 2002;40:240-5.
85. Van Lente F, McErlean ES, DeLuca SA, Peacock WF, Rao JS, Nissen SE. Ability of troponins to predict adverse out-comes in patients with renal insufficiency and suspected acute coronary syndromes: A case-matched study. J Am Coll Cardiol 1999;33:471-8.
86. Cardinale D, Sandri MT, Martinoni A, Borghini E, Civelli M, Lamantia G, et al. Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy. Ann Oncol 2002 May; 13:710-5.
87. Giannitsis E, Mullerbardorff M, Kurowski V, Weidtmann B, Wiegand UH, Kampmann M, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000;102:211-7.
88. Konstantinides S, Geibel A, Olschewski M, Kasper W, Hruska N, Jackle S, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002 Sep 3;106: 1263-8.